Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.

Biotechnology

Pyxis Oncology

Lara S. Sullivan

Michiel Meerleveld

Breana Loreaux

Donna Regalado

Ator Jallo

Weitang Chen

Leah Lyons

Jitu Wadhane

Michael Bui

Ken Kobayashi

Xiaodong Yang

Balu Balasubramanian

Jan Pinkas

Pamela Connealy

The Research and Development team at Pyxis Oncology is dedicated to advancing innovative cancer therapies, focusing on the development and optimization of antibody-drug conjugates and monoclonal antibody immunotherapies. This multidisciplinary group collaborates on drug discovery, clinical operations, and regulatory compliance, ensuring the successful transition of potent biologics from the lab to clinical trials, ultimately aiming to improve outcomes for patients with challenging cancers.

Research and Development

Leadership Team

Human Resources and Administrative Support

Research and Development

About

Team members

Other teams at Pyxis Oncology

Leadership Team

Human Resources and Administrative Support